The regulation of MDM2 oncogene and its impact on human cancers

被引:136
作者
Zhao, Yuhan [1 ]
Yu, Haiyang [1 ]
Hu, Wenwei [1 ,2 ]
机构
[1] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, Dept Pharmacol, New Brunswick, NJ 08903 USA
基金
美国国家卫生研究院;
关键词
MDM2; E3 ubiquitin ligase; gene regulation; p53; TUMOR-SUPPRESSOR PATHWAY; P53-MDM2 FEEDBACK LOOP; UBIQUITIN LIGASE ACTIVITY; RIBOSOMAL-PROTEIN L26; LI-FRAUMENI-SYNDROME; DNA-DAMAGE; ACTIVATES P53; MUTANT P53; P53-DEPENDENT MANNER; ONCOPROTEIN MDM2;
D O I
10.1093/abbs/gmt147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor p53 plays a central role in preventing tumor formation. The levels and activity of p53 is under tight regulation to ensure its proper function. Murine double minute 2 (MDM2), a p53 target gene, is an E3 ubiquitin ligase. MDM2 is a key negative regulator of p53 protein, and forms an auto-regulatory feedback loop with p53. MDM2 is an oncogene with both p53-dependent and p53-independent oncogenic activities, and often has increased expression levels in a variety of human cancers. MDM2 is highly regulated; the levels and function of MDM2 are regulated at the transcriptional, translational and post-translational levels. This review provides an overview of the regulation of MDM2. Dysregulation of MDM2 impacts significantly upon the p53 functions, and in turn the tumorigenesis. Considering the key role that MDM2 plays in human cancers, a better understanding of the regulation of MDM2 will help us to develop novel and more effective cancer therapeutic strategies to target MDM2 and activate p53 in cells.
引用
收藏
页码:180 / 189
页数:10
相关论文
共 119 条
[31]  
Fridman JS, 2003, CANCER RES, V63, P5703
[32]   MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation [J].
Fu, Wei ;
Ma, Qiuping ;
Chen, Lei ;
Li, Pengfei ;
Zhang, Mu ;
Ramamoorthy, Sivapriya ;
Nawaz, Zafar ;
Shimojima, Tsukasa ;
Wang, Hengbin ;
Yang, Yonghua ;
Shen, Zheng ;
Zhang, Yingtao ;
Zhang, Xiaohong ;
Nicosia, Santo V. ;
Zhang, Yanping ;
Pledger, Jack W. ;
Chen, Jiandong ;
Bai, Wenlong .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (21) :13987-14000
[33]   The p53 mRNA-Mdm2 Interaction Controls Mdm2 Nuclear Trafficking and Is Required for p53 Activation following DNA Damage [J].
Gajjar, Madhavsai ;
Candeias, Marco M. ;
Malbert-Colas, Laurence ;
Mazars, Anne ;
Fujita, Jun ;
Olivares-Illana, Vanesa ;
Fahraeus, Robin .
CANCER CELL, 2012, 21 (01) :25-35
[34]   Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation [J].
Goldberg, Z ;
Vogt Sionov, R ;
Berger, M ;
Zwang, Y ;
Perets, R ;
Van Etten, RA ;
Oren, M ;
Taya, Y ;
Haupt, Y .
EMBO JOURNAL, 2002, 21 (14) :3715-3727
[35]   Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization [J].
Graves, Bradford ;
Thompson, Thelma ;
Xia, Mingxuan ;
Janson, Cheryl ;
Lukacs, Christine ;
Deo, Dayanand ;
Di Lello, Paola ;
Fry, David ;
Garvie, Colin ;
Huang, Kuo-Sen ;
Gao, Lin ;
Tovar, Christian ;
Lovey, Allen ;
Wanner, Jutta ;
Vassilev, Lyubomir T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (29) :11788-11793
[36]   p300/MDM2 complexes participate in MDM2-mediated p53 degradation [J].
Grossman, SR ;
Perez, M ;
Kung, AL ;
Joseph, M ;
Mansur, C ;
Xiao, ZX ;
Kumar, S ;
Howley, PM ;
Livingston, DM .
MOLECULAR CELL, 1998, 2 (04) :405-415
[37]   Regulation of XIAP Translation and Induction by MDM2 following Irradiation [J].
Gu, Lubing ;
Zhu, Ningxi ;
Zhang, Hongying ;
Durden, Donald L. ;
Feng, Yue ;
Zhou, Muxiang .
CANCER CELL, 2009, 15 (05) :363-375
[38]   A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1 [J].
Hara, Makoto R. ;
Kovacs, Jeffrey J. ;
Whalen, Erin J. ;
Rajagopal, Sudarshan ;
Strachan, Ryan T. ;
Grant, Wayne ;
Towers, Aaron J. ;
Williams, Barbara ;
Lam, Christopher M. ;
Xiao, Kunhong ;
Shenoy, Sudha K. ;
Gregory, Simon G. ;
Ahn, Seungkirl ;
Duckett, Derek R. ;
Lefkowitz, Robert J. .
NATURE, 2011, 477 (7364) :349-U129
[39]   MDM2 splice variants and their therapeutic implications [J].
Harris, LC .
CURRENT CANCER DRUG TARGETS, 2005, 5 (01) :21-26
[40]   Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay [J].
Herman, Ariel G. ;
Hayano, Miki ;
Poyurovsky, Masha V. ;
Shimada, Kenichi ;
Skouta, Rachid ;
Prives, Carol ;
Stockwell, Brent R. .
CANCER DISCOVERY, 2011, 1 (04) :312-325